שולי רווח נקי Bionano Genomics, Inc. (BNGO)

Bionano Genomics, Inc. (BNGO) is scaling DNA analysis through strategic alliances with laboratories and the implementation of AI. The technological superiority of Saphyr and patent protection create a significant barrier to entry for competitors. Market capitalization is based on the deployment of hardware and software. The net sales yield ratio on the GURU.Markets terminal chart shows that the indicator is at -96.90.
פילוחי נתונים אנליטיים מרוכזים עבור Bionano Genomics Inc. (BNGO)

Sales margins serve as a key filter during asset stress testing to evaluate actual profitability. This ratio measures the share of net profit in total revenue, demonstrating the ultimate efficiency of cost management. By analyzing net margin dynamics, an investor can see the ability of Bionano Genomics, Inc. (BNGO) to monetize the delivery of equipment and software. An increase in this indicator confirms the optimization of production costs for genome mapping systems, while a decrease signals rising costs in the implementation of high-tech products.